121 related articles for article (PubMed ID: 34294413)
1. Why not de-intensification for uterine cervical cancer?
Murakami N; Ando K; Murata M; Murata K; Ohno T; Aoshika T; Kato S; Okonogi N; Saito AI; Kim JY; Kumai Y; Yoshioka Y; Sekii S; Tsujino K; Lowanichkiattikul C; Pattaranutaporn P; Kaneyasu Y; Nakagawa T; Watanabe M; Uno T; Umezawa R; Jingu K; Kanemoto A; Wakatsuki M; Shirai K; Igaki H; Itami J
Gynecol Oncol; 2021 Oct; 163(1):105-109. PubMed ID: 34294413
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
[TBL] [Abstract][Full Text] [Related]
3. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
4. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
[TBL] [Abstract][Full Text] [Related]
5. Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?
Horne ZD; Karukonda P; Kalash R; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Bochmeier MM; Berger JL; Taylor SE; Sukumvanich P; Beriwal S
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):157-164. PubMed ID: 30605752
[TBL] [Abstract][Full Text] [Related]
6. An Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma.
Murakami N; Ando K; Murata M; Murata K; Ohno T; Aoshika T; Kato S; Okonogi N; Saito AI; Kim JY; Yoshioka Y; Sekii S; Tsujino K; Lowanichkiattikul C; Pattaranutaporn P; Kaneyasu Y; Nakagawa T; Watanabe M; Uno T; Umezawa R; Jingu K; Kanemoto A; Wakatsuki M; Shirai K; Igaki H; Itami J
J Radiat Res; 2022 May; 63(3):412-427. PubMed ID: 35446962
[TBL] [Abstract][Full Text] [Related]
7. Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-dose-rate brachytherapy for cervical cancer.
Otter S; Coates A; Franklin A; Cunningham M; Stewart A
Brachytherapy; 2018; 17(3):580-586. PubMed ID: 29426744
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session.
Oh D; Huh SJ; Park W; Ju SG; Nam H; Lee JE
Medicine (Baltimore); 2016 Jun; 95(25):e3895. PubMed ID: 27336876
[TBL] [Abstract][Full Text] [Related]
9. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
11. A volumetric analysis of GTV
Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
[TBL] [Abstract][Full Text] [Related]
12. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
[TBL] [Abstract][Full Text] [Related]
13. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
14. Is it time to modify the Japanese Uterine Cervical Cancer Guidelines to recommend a higher dose for radio-resistant tumors?
Murakami N; Okuma K; Takahashi A; Kato T; Igaki H
Jpn J Clin Oncol; 2023 Jan; 53(2):179-181. PubMed ID: 36373890
[TBL] [Abstract][Full Text] [Related]
15. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of planning aims and dose prescription in image-guided adaptive brachytherapy and radiochemotherapy for cervical cancer: Vienna clinical experience in 225 patients from 1998 to 2008.
Majercakova K; Pötter R; Kirisits C; Banerjee S; Sturdza AE; Georg P; Nesvacil N; Schmid MP
Acta Oncol; 2015; 54(9):1551-7. PubMed ID: 26198658
[TBL] [Abstract][Full Text] [Related]
17. Tumor dose-volume response in image-guided adaptive brachytherapy for cervical cancer: A meta-regression analysis.
Mazeron R; Castelnau-Marchand P; Escande A; Rivin Del Campo E; Maroun P; Lefkopoulos D; Chargari C; Haie-Meder C
Brachytherapy; 2016; 15(5):537-42. PubMed ID: 27371991
[TBL] [Abstract][Full Text] [Related]
18. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
19. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
[TBL] [Abstract][Full Text] [Related]
20. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
